FindTrial
Sign In

Uterine Artery Embolization with and without Local Methotrexate Infusion for the Treatment of Cesarean Scar Pregnancy

Uterine Artery Embolization with and without Local Methotrexate Infusion for the Treatment of Cesarean Scar Pregnancy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010533
Enrollment
Unknown
Registered
2017-01-29
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Scar Pregnancy

Interventions

UAE group:UAE only before curettage
UAE+ MTX group:UAE with local MTX infusion before curettage

Sponsors

Taizhou Hospital of Zhejiang Province, Affiliated with Wenzhou Medical College,
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Cesarean scar pregnancy patients with stable condition

Exclusion criteria

Exclusion criteria: Patients with a ruptured uterus, inevitable abortion, active inflammation, severe cardiac, lung, kidney, or liver disease, or allergy to iodinated contrast medium, MTX, or embolic material were excluded.

Design outcomes

Primary

MeasureTime frame
Success rate;Complication rate;—

Secondary

MeasureTime frame
Hospitalization cost;Time of recovery;Amount of bleeding;—

Countries

China

Contacts

Public ContactFeng Qi

Taizhou Hospital of Zhejiang Province, Affiliated with Wenzhou Medical College,

wolovetheworld@163.com+86 13738667909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026